Queen City Angels
VC Fund
Cincinnati, United States
Queen City Angels (QCA) is a group of experienced, accredited investors committed to accelerating the growth of early-stage businesses.
- Total investments:
- 58
- Last investment:
- Lead investor:
- 21%
- Fund size:
- $10M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Queen City Angels invests in
Health CareSoftwareMedicalE-CommerceBiotechnology
Stages Queen City Angels invests in
SeedSeries AFunding RoundPre-SeedAngel
Countries Queen City Angels invests in
United States
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
John A. Kraeutler
|
|||
Laura Duerring
|
|||
|
Ted Capossela
|
|||
Tricia Collins
|
|||
Dan Kincaid
|
Investment Focus
Industry
- Health Care 13 (22%)
- Software 10 (17%)
- Medical 5 (9%)
- E-Commerce 5 (9%)
- Biotechnology 5 (9%)
Stage
- Seed 17 (29%)
- Series A 13 (22%)
- Funding Round 6 (10%)
- Pre-Seed 4 (7%)
- Angel 3 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
John A. Kraeutler
Investor Member
|
Investor Member | Total investments: 0 | Find email | |
|
Laura Duerring
Member Investor
|
Member Investor | Total investments: 0 | Find email | |
|
Ted Capossela
spokesman
|
spokesman | Total investments: 1 | Find email | |
|
Tricia Collins
Operations Manager
|
Operations Manager | Total investments: 0 | Find email | |
|
Dan Kincaid
Investor Member
|
Investor Member | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TeamCentral
|
TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems. | $3.9M / Seed / May 27, 2025 | |
SureImpact
|
SureImpact creates an impact management and reporting solution for social-good organizations and their funders. SureImpact elevates service coordination by assisting mission-driven professionals in moving beyond simply measuring what they did (outputs) to how individuals, families, and communities benefit (outcomes and impact). SureImpact solutionsare specifically designed for the non-profit sector to capture invaluable insights that can be used to improve their organization's delivery of mission-critical services, engage their communities, attract new sources of funding, and increase trust among their constituents. | $2M / Seed / Apr 06, 2023 | |
Tactile Engineering
|
Tactile Engineering develops and manufactures affordable tactile graphics tablets for use by blind and visually impaired individuals. | $1.5M / Venture - Series Unknown / Feb 16, 2023 | |
C360 Technologies
|
C360 Technologies is a video technology that delivers quality non-stitched immersive video products to date. C360 is a different kind of 360/VR company. Unlike most, they don’t stitch or require multi-headed cameras to deliver our stunning 6K immersive broadcast and streaming video. They've worked in the industry since 2008 pioneeringoriginal 360 technologies that continue to deliver the highest quality, non-stitched immersive video in the world. Their live output for linear broadcast and OTT streaming platforms coupled with the industry's smallest pro-grade immersive camera is unique compared to others. C360 delivers multiple HD-SDI outputs directly to the broadcast backhaul for live television events while simultaneously delivering a 4K stream to the OTT platform for distribution across VR and second screen (magic screen) applications. Unlimited users are now empowered to independently control their camera location and P/T/Z during the live event.The company was founded in 2008 and is headquartered in Wexford, Pennsylvania. | Venture - Series Unknown / Oct 11, 2022 | |
Alphyn Biologics
|
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform. | $3.3M / Series A / Sep 15, 2022 | |
Cloverleaf.me
|
Cloverleaf improves team dynamics by integrating disconnected HR data and insights into personalized, actionable development experiences at scale. Cloverleaf enables personalized coaching, clearer communication, and stronger team alignment throughout the entire employee lifecycle. Built upon validated behavioral assessments and real-timeperformance insights, Cloverleaf empowers managers and teams to collaborate effectively, resolve challenges proactively, and unlock greater human potential. Trusted by more than 30,000 teams, Cloverleaf helps organizations create cohesive, aligned teams, improving employee performance, engagement, and productivity. For more information, visit cloverleaf.me. | $9M / Series A / Jun 09, 2022 | |
AKRU
|
AKRU’s commercial real estate investment platform uses blockchain technology to create a secure and easy-to-use marketplace. AKRU offers investors the opportunity for fractionalized ownership for as low as $1,000 in the form of security tokens. The platform’s technology enables instantaneous transactions to be recorded on an immutable ledger,building investor trust. Tokenization shortens the transaction cycle and is able to compress the closing and settlement period of assets to mere seconds – making the world’s largest investment class more accessible and liquid for investors. Since launching the paid beta in October 2020, AKRU has secured 14 assets and over 50 investors for the marketplace. AKRU relaunched its platform in March of 2021 as the Title Sponsor for the Security Token Summit. Akru has been mentioned in major publications like Coin Telegraph, Investor.com, securities.io & Business Journals. | $2M / Seed / Sep 07, 2021 | |
Resonado Labs
|
Resonado Labs develops innovative audio hardware solutions that deliver a wide spectrum of new possibilities for sound reproduction. We are on a mission to bring real innovation to the audio market, starting at the hardware level. We have developed audio hardware products ranging from miniaturized sub-woofer drivers for all-in-one integrated soundbars to long range sonic projection arrays capable of delivering a hyper directed sound beam audible at distances of over 1500m. With a core focus on transducer design and engineering, we are capable of high velocity innovation and development on a never ending quest to continually improve the acoustic performance of our products through endless experimentations with materials, motor structure architectures, industrial and system designs. We are pushing our proprietary transducer technology into new industries through both simulation engineering environments and rapid prototyping with physical materials on site at our Chicago headquarters and in conjunction with our commercial partners. | $3M / Seed / Jul 20, 2021 | |
Kurome Therapeutics
|
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms. | $15M / Series A / Jun 10, 2021 | |
Standard Bariatrics
|
Standard Bariatrics is a medical device company that develops and offers surgical instruments for weight-loss surgeries.The company offers Standard Clamp, an instrument that helps surgeons standardize their individual techniques to reduce variation, improve efficiency, and eliminate waste when performing a laparoscopic sleeve gastrectomy.Standard Bariatrics was founded in 2014 and is based in Cincinnati, Ohio. | $35M / Series B / Jun 01, 2021 | |
| See all 58 investments → | |||
Co-Investors
QCA Ventures
12 deals together
CincyTech
10 deals together
North Coast Ventures
8 deals together
Rev1 Ventures
6 deals together
Connetic Ventures
5 deals together
Cincinnati Children’s
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Marketplace Investors
40,654 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
FAQ
What does Queen City Angels invest in?
Queen City Angels invests primarily in Health Care, Software and Medical startups, most often at Seed and Series A stage. Most of the 58 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Queen City Angels?
Public channels for Queen City Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Queen City Angels?
The team at Queen City Angels includes John A. Kraeutler (Investor Member), Laura Duerring (Member Investor) and Ted Capossela (spokesman), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
